Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:2338-2345

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravalli, S.
Right arrow Articles by Cannon, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravalli, S.
Right arrow Articles by Cannon, P. J.

(Circulation. 1998;97:2338-2345.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Inducible Nitric Oxide Synthase Expression in Smooth Muscle Cells and Macrophages of Human Transplant Coronary Artery Disease

Stefano Ravalli, MD; Arline Albala, MA; Ming Ming, PhD; Matthias Szabolcs, MD; Alessandro Barbone; Robert E. Michler, MD; ; Paul J. Cannon, MD

From the Departments of Medicine (S.R., A.A., M.M., A.B., P.J.C.), Pathology (M.S.), and Surgery (R.E.M.), Columbia University College of Physicians and Surgeons, New York, NY.

Correspondence to Paul J. Cannon, MD, Department of Medicine, Division of Cardiology, Columbia University, 630 W 168th St, New York, NY 10032.

Background—The inducible isoform of the nitric oxide synthase (iNOS) produces large amounts of nitric oxide in response to cytokine stimulation. Previous investigations have demonstrated iNOS expression in the setting of acute and chronic rejection in experimental cardiac transplant models. The goal of this study was to investigate whether iNOS is upregulated in human transplant coronary artery disease (TCAD), a major cause of late mortality after cardiac transplantation.

Methods and Results—We studied 15 patients with TCAD and 10 with normal coronary arteries. In situ hybridization and immunohistochemistry were used in tissue sections to localize iNOS mRNA and protein, respectively. The presence of peroxynitrite was indirectly assessed by immunostaining with an anti-nitrotyrosine antibody. Normal coronary arteries had no evidence of iNOS expression. In contrast, 30 of 36 coronary artery segments with TCAD (83%) were immunostained by the iNOS antibody. The presence of iNOS mRNA was demonstrated in these vessels by in situ hybridization. Specific cell markers identified iNOS-positive cells as neointimal macrophages and smooth muscle cells. Nitrotyrosine immunoreactivity colocalized with iNOS expression in arteries with TCAD, distributed in macrophages and smooth muscle cells.

Conclusions—iNOS mRNA and protein are expressed in human arteries with TCAD, where they are associated with extensive nitration of protein tyrosines. These findings indicate that the high-output nitric oxide pathway and possibly the oxidant peroxynitrite might be involved in the process leading to the development of TCAD.


Key Words: arteriosclerosis • endothelium-derived factors • transplantation




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
P. Pacher and C. Szabo
Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
Am. J. Pathol., July 1, 2008; 173(1): 2 - 13.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. G. Dickhout, G. S. Hossain, L. M. Pozza, J. Zhou, S. Lhotak, and R. C. Austin
Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Hemmrich, C. V. Suschek, G. Lerzynski, and V. Kolb-Bachofen
iNOS activity is essential for endothelial stress gene expression protecting against oxidative damage
J Appl Physiol, November 1, 2003; 95(5): 1937 - 1946.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. KOSAKA, H. YONEYAMA, L. ZHANG, S. FUJII, A. YAMAMOTO, and J. IGARASHI
Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine
FASEB J, April 1, 2003; 17(6): 636 - 643.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Szabolcs, J. Sun, N. Ma, A. Albala, R. R. Sciacca, G. B. Philips, J. Parkinson, N. Edwards, and P. J. Cannon
Effects of Selective Inhibitors of Nitric Oxide Synthase-2 Dimerization on Acute Cardiac Allograft Rejection
Circulation, October 29, 2002; 106(18): 2392 - 2396.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Yen, G. Pilkington, R. C. Starling, N. B. Ratliff, P. M. McCarthy, J. B. Young, G. M. Chisolm, and M. S. Penn
Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy
Circulation, September 10, 2002; 106(11): 1379 - 1383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Qian, R. Gelzer-Bell, S.-x. Yang, W. Cao, T. Ohnishi, B. A. Wasowska, R. H. Hruban, E. R. Rodriguez, W. M. Baldwin III, and C. J. Lowenstein
Inducible Nitric Oxide Synthase Inhibition of Weibel-Palade Body Release in Cardiac Transplant Rejection
Circulation, November 6, 2001; 104(19): 2369 - 2375.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Wildhirt, M. Weis, C. Schulze, N. Conrad, S. Pehlivanli, G. Rieder, G. Enders, W. von Scheidt, and B. Reichart
Expression of Endomyocardial Nitric Oxide Synthase and Coronary Endothelial Function in Human Cardiac Allografts
Circulation, September 18, 2001; 104 (2009): I-336 - I-343.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. M. Wildhirt, M. Weis, C. Schulze, N. Conrad, S. Pehlivanli, G. Rieder, G. Enders, W. von Scheidt, and B. Reichart
Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans
Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 840 - 847.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sasu, A. L. Cooper, and D. Beasley
Juxtacrine effects of IL-1{alpha} precursor promote iNOS expression in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1615 - H1623.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Weiland, J. Haendeler, C. Ihling, U. Albus, W. Scholz, H. Ruetten, A. M. Zeiher, and S. Dimmeler
Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway
Cardiovasc Res, February 1, 2000; 45(3): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Metais, J. Li, J. Li, M. Simons, and F. W. Sellke
Serotonin-Induced Coronary Contraction Increases After Blood Cardioplegia-Reperfusion : Role of COX-2 Expression
Circulation, November 9, 1999; 100 (2009): II-328 - II-334.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Kibbe, T. Billiar, and E. Tzeng
Inducible nitric oxide synthase and vascular injury
Cardiovasc Res, August 15, 1999; 43(3): 650 - 657.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. L. Glenn, W. Y. S. Wang, and B. J. Morris
Different Frequencies of Inducible Nitric Oxide Synthase Genotypes in Older Hypertensives
Hypertension, April 1, 1999; 33(4): 927 - 932.
[Abstract] [Full Text] [PDF]